Natural sciences

Global Copper Additive Manufacturing Market 2021-2026 by Product Type, Manufacturing Techniques, Application and Geography - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021

Copper additives help companies to develop complex shapes and personalized items in a low wasteful manufacturing process.

Key Points: 
  • Copper additives help companies to develop complex shapes and personalized items in a low wasteful manufacturing process.
  • Increasing demand for copper additives in various verticals of the industry is a major factor driving the growth of the companies.
  • The growing R&D investment in technologies and copper additives is likely to create lucrative opportunities for the market.
  • Copper is extremely reflective and tends to absorb lasers during additive manufacturing, resulting in low product quality.

PCR Molecular Diagnostics Market Research Report 2021 - Global Growth, Trends, COVID-19 Impact, and Forecasts to 2026 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 3, 2021

The "PCR Molecular Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "PCR Molecular Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
  • The PCR Molecular Diagnostics market is expected to grow with an estimated CAGR of 3.5%, over the forecast period.
  • Though COVID 19 has a major impact on the medical industry, the PCR Molecular Diagnostics market is on a positive trend.
  • The rising prevalence of cancer and infectious diseases is also a major factor that drives PCR molecular diagnostics market.

SHIELD Illinois Establishes 7th COVID-Test Laboratory at Rosalind Franklin University Innovation and Research Park

Retrieved on: 
Tuesday, August 3, 2021

"The new SHIELD Illinois site at our Innovation and Research Park is an important addition to our university, community and region given the increased COVID-19 infection rate of unvaccinated populations," said Dr. Ronald Kaplan, RFU executive vice president for research.

Key Points: 
  • "The new SHIELD Illinois site at our Innovation and Research Park is an important addition to our university, community and region given the increased COVID-19 infection rate of unvaccinated populations," said Dr. Ronald Kaplan, RFU executive vice president for research.
  • SHIELD Illinois testing is free to all of the state's public schools outside of Chicago through an agreement with the Illinois Department of Public Health.
  • The university embodies the spirit of inquiry and excellence modeled by its namesake Dr. Rosalind Franklin, whose Photo 51 was crucial to solving the structure of DNA.
  • A nonprofit unit of the University of Illinois System, SHIELD Illinois is dedicated to providing its innovative, saliva-based PCR COVID-19 testing across the state.

Johnson Matthey taps Kebotix's AI capabilities to enhance digital strategy

Retrieved on: 
Tuesday, August 3, 2021

The project will support JM's digital strategy, and help to bring the London-headquartered company to the forefront of digital R&D.

Key Points: 
  • The project will support JM's digital strategy, and help to bring the London-headquartered company to the forefront of digital R&D.
  • Kebotix's lab-of-the-future AI capabilities has the potential to enhance JM's digital transformation in the chemical industry.
  • The collaboration will seek to discover innovative methods to increase the efficiency of experiments leading to the optimisation of catalytic converter coating formulations.
  • By automating the scientific method using a proprietary closed-loop R&D process to predict and produce new chemistries, Kebotix's digital platform empowers lab researchers.

Self-developed lithium Ion battery product, by one of Ionix Technology, Inc.'s wholly-owned subsidiaries has passed the test of China National Institute of Chemical Power Sources for Light Industry and obtained the test report

Retrieved on: 
Tuesday, August 3, 2021

China National Institute of Chemical Power Sources for Light Industry is the only professional institute specialized in the research and testing of chemical power sources in the Ministry of Light Industry.

Key Points: 
  • China National Institute of Chemical Power Sources for Light Industry is the only professional institute specialized in the research and testing of chemical power sources in the Ministry of Light Industry.
  • The impartiality, scientific and authority of the institute has been unanimously recognized by the industry.
  • According to the test report content, the discharge capacity of the battery at minus 50can reach more than 95% of the normal temperature discharge capacity.
  • Ionix Technology, Inc. is a holding company that is principally engaged in the photoelectric display and smart energy industries.

Emmersion Rebrands to Reflect How It's Closing the Global Communication Gap

Retrieved on: 
Tuesday, August 3, 2021

Emmersion is designed to help organizations find the right fit for their team through adaptive language testing that prove language ability.

Key Points: 
  • Emmersion is designed to help organizations find the right fit for their team through adaptive language testing that prove language ability.
  • Each language assessment is curated by artificial intelligence that adjusts the assessment to an individual's ability.
  • Founded in 2015, Emmersion is a rapidly growing human resources technology company located on the Silicon Slopes of Lehi, Utah.
  • With a mission to close the global communication gap, the company focuses on helping organizations be smarter with their global language strategy.

ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at BTIG's Virtual Biotechnology Conference 2021

Retrieved on: 
Tuesday, August 3, 2021

To learn more about ZyVersa and its inflammasome ASC inhibitor, IC 100, or its phase 2a-ready cholesterol efflux mediator for renal disease (VAR 200), please request a one-on-one meeting.

Key Points: 
  • To learn more about ZyVersa and its inflammasome ASC inhibitor, IC 100, or its phase 2a-ready cholesterol efflux mediator for renal disease (VAR 200), please request a one-on-one meeting.
  • ZyVersa is a clinical stage specialty biopharmaceutical company leveraging advanced, proprietary technologies to develop first-in-class drugs.
  • Our focus is on patients with inflammatory or renal diseases who have significant unmet medical needs.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/zyversa-therapeutics-ceo-stephe...

Singular Genomics Systems, Inc. Announces Second Quarter Financial Results and Operations Update

Retrieved on: 
Tuesday, August 3, 2021

* Operating expenses for the second quarter of 2021 included non-cash stock-based compensation of$2.3 million.

Key Points: 
  • * Operating expenses for the second quarter of 2021 included non-cash stock-based compensation of$2.3 million.
  • Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians.
  • Our mission is to accelerate genomics for the advancement of science and medicine.
  • Our second integrated solution in development, the PX Integrated Solution, combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument to offer a versatile multiomics solution.

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Tuesday, August 3, 2021

The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
  • Each stock option has a 10-year term and is subject to the terms and conditions of BioCrysts Inducement Equity Incentive Plan and a stock option agreement covering the grant.
  • BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease.
  • RAPIVAB (peramivir injection), a viral neuraminidase inhibitor for the treatment of influenza, has received regulatory approval in the U.S., Canada, Australia, Japan, Taiwan and Korea.

SunHydrogen Shares New Video Spotlighting its Green Hydrogen Technology and the Global Hydrogen Market

Retrieved on: 
Tuesday, August 3, 2021

SANTA BARBARA, CA , Aug. 03, 2021 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTC:HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, this week shared a new video that showcases its nanoparticle-based green hydrogen technology, placing it in the context of the fast-growing global hydrogen market.

Key Points: 
  • SANTA BARBARA, CA , Aug. 03, 2021 (GLOBE NEWSWIRE) -- SunHydrogen, Inc. (OTC:HYSR), the developer of a breakthrough technology to produce renewable hydrogen using sunlight and water, this week shared a new video that showcases its nanoparticle-based green hydrogen technology, placing it in the context of the fast-growing global hydrogen market.
  • Were excited to continue utilizing video communication to connect with our audience across all platforms as we make progress toward commercialization.
  • The video highlights the efficiency and versatility that SunHydrogens technology offers as the world moves rapidly toward clean energy solutions.
  • SunHydrogen is developing a breakthrough, low-cost technology to make renewable hydrogen using sunlight and any source of water, including seawater and wastewater.